{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:23:49Z","timestamp":1777955029654,"version":"3.51.4"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1086\/507333","type":"journal-article","created":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T20:01:45Z","timestamp":1154980905000},"page":"645-653","source":"Crossref","is-referenced-by-count":125,"title":["Current Concepts in the Diagnosis and Management of Metabolic Complications of HIV Infection and Its Therapy"],"prefix":"10.1093","volume":"43","author":[{"given":"D. A.","family":"Wohl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"McComsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tebas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Glesby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Reeds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Shikuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Revuelta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Swindells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fichtenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Basar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tungsiripat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Weihe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"rf1_585","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126334-200211010-00001","volume":"31","author":"Schambelan M","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf2_586","doi-asserted-by":"publisher","DOI":"10.1086\/378131"},{"key":"rf3_587","doi-asserted-by":"publisher","DOI":"10.1086\/498511"},{"key":"rf4_588","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11908-006-0012-x","volume":"8","author":"Brown TT","year":"2006","journal-title":"Curr Infect Dis Rep"},{"key":"rf5_589","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00126334-200104150-00006","volume":"26","author":"Mulligan K","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf6_590","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000182230.47819.aa"},{"key":"rf7_591","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107270-00008"},{"key":"rf8_592","first-page":"15","volume":"10","author":"Parker RA","year":"2005","journal-title":"Ireland. Antiviral Therapy"},{"key":"rf9_593","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200501010-00004"},{"key":"rf10_594","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/01.aids.0000183629.20041.bb","volume":"19","author":"Dube MP","year":"2005","journal-title":"AIDS"},{"key":"rf11_595","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200105040-00005"},{"key":"rf12_596","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00001"},{"key":"rf13_597","unstructured":"Cohen C, Shen Y, Rode R, etal Effect of nucleoside intensification on prevalence of morphologic abnormalities at year 5 of ritonavir plus saquinavir therapy in an HIV-infected cohort [abstract 683]. In: Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Available at: http:\/\/www.retroconference.org\/2002\/Posters\/13596.pdf. Accessed 24 July 2006."},{"key":"rf14_598","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200212060-00010"},{"key":"rf15_599","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.2.191"},{"key":"rf16_600","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200007070-00002"},{"key":"rf17_601","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"rf18_602","doi-asserted-by":"publisher","DOI":"10.1021\/bi035596s"},{"key":"rf19_603","doi-asserted-by":"publisher","DOI":"10.1086\/343050"},{"key":"rf20_604","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.2.207"},{"key":"rf21_605","doi-asserted-by":"publisher","DOI":"10.1086\/380790"},{"key":"rf22_606","unstructured":"Moyle G, Sabin C, Cartledge J, etal A 48 week, randomized, open-label comparative study of tenofovir DF vs. abacavir as substitutes for a thymidine analog in persons with lipoatrophy and sustained virological suppression on HAART [abstract 44LB]. In: Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections (Boston). Available at: http:\/\/www.retroconference.org\/2005\/cd\/Abstracts\/25752.htm. Accessed 24 July 2006."},{"key":"rf23_607","unstructured":"Murphy R, Zhang J, Hafner R, etal Switching to a thymidine analog-sparing or a nucleoside-sparing regimen improves lipoatrophy: 24 week results of a prospective randomized clinical trial, AACTG 5110 [abstract 45LB]. In: Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections (Boston). Available at: http:\/\/www.retroconference.org\/2005\/cd\/Abstracts\/25715.htm. Accessed 24 July 2006."},{"key":"rf24_608","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","volume":"140","author":"Hadigan C","year":"2004","journal-title":"Ann Intern Med"},{"key":"rf25_609","unstructured":"Tebas P, Zhang J, Yarasheski K, etal Switch to a protease inhibitor-containing\/nucleoside reverse transcriptase inhibitor-sparing regimen increases at end to let fat and serum lipid levels without affecting glucose metabolism or bone mineral density: the results of a prospective randomised trial, ACTG5125s [abstract 40]. In: Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections (Boston). Available at: http:\/\/www.retroconference.org\/2005\/cd\/Abstracts\/24545.htm. Accessed 24 July 2006."},{"key":"rf26_610","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00126334-200210010-00006","volume":"31","author":"Gelato MC","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf27_611","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-143-5-200509060-00009","volume":"143","author":"van Wijk JP","year":"2005","journal-title":"Ann Intern Med"},{"key":"rf28_612","unstructured":"Mulligan K, Yang Y, Koletar S, etal Effects of metformin and rosiglitazone on body composition in HIV-infected patients with hyperinsulinemia and elevated waist\/hip ratio: a randomized, placebo-controlled trial [abstract 147]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Available at: http:\/\/www.retroconference.org\/2006\/Abstracts\/27715.htm. Accessed 24 July 2006."},{"key":"rf29_613","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15489-5"},{"key":"rf30_614","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","volume":"8","author":"Sutinen J","year":"2003","journal-title":"Antivir Ther"},{"key":"rf31_615","unstructured":"Slama L, Lanoy E, Valentin MA, etal Effect of pioglitazone on HIV-1 related lipoatrophy: a randomized double-blind placebo-controlled trial (ANRS 113) with 130 patients [abstract 151LB]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Available at: http:\/\/www.retroconference.org\/2006\/Abstracts\/27920.htm. Accessed 24 July 2006."},{"key":"rf32_616","unstructured":"Sutinen J, Walker UA, Hakkinen AM, etal Uridine for the treatment of HAART-associated lipodystrophy: a randomized, double-blind, placebo-controlled trial [abstract PS5\/6]. In: Program and abstracts of the 10th European AIDS Conference (Dublin). 2005."},{"key":"rf33_617","unstructured":"McComsey GA, Setzer B, O\u2019Riordan M, etal NucleomaxX improves clinical lipoatrophy without any change in fat mitochondrial DNA levels [abstract LBPE9.4\/8]. In: Program and abstracts of the 10th European AIDS Conference (Dublin). 2005."},{"key":"rf34_618","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11904-005-0005-7","volume":"2","author":"Moyle G","year":"2005","journal-title":"Curr HIV\/AIDS Rep"},{"key":"rf35_619","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000138420.38995.86"},{"key":"rf36_620","first-page":"S5","volume":"13","author":"Kotler D","year":"2003","journal-title":"AIDS Read"},{"key":"rf37_621","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000182230.47819.aa"},{"key":"rf38_622","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.311.6998.158","volume":"311","author":"Lean ME","year":"1995","journal-title":"BMJ"},{"key":"rf39_623","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907300-00015"},{"key":"rf40_624","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.472"},{"key":"rf41_625","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905280-00023"},{"key":"rf42_626","unstructured":"Kohli R, Wanke C, Gorbach S, Shevitz A. A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy [abstract 148]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Available at: http:\/\/www.retroconference.org\/2006\/Abstracts\/27142.htm. Accessed 24 July 2006."},{"key":"rf43_627","unstructured":"Shikuma C, Parker R, Sattler F, etal Effects of physiologic testosterone supplementation on fat mass and distribution in HIV-infected men with abdominal obesity: ACTG 5079 [abstract 149]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Available at: http:\/\/www.retroconference.org\/2006\/Abstracts\/27165.htm. Accessed 24 July 2006."},{"key":"rf44_628","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200403010-00004"},{"key":"rf45_629","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041811"},{"key":"rf46_630","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.2.210"},{"key":"rf47_631","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000180099.35146.30"},{"key":"rf48_632","unstructured":"Malan N, Krantz E, David N, etal Efficacy and safety of atazanavir-based therapy in antiretroviral naive HIV-1 infected subjects, both with and without ritonavir: 48-week results from AI424-089 [abstract 107LB]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Available at: http:\/\/www.retroconference.org\/2006\/Abstracts\/27965.htm. Accessed 24 July 2006."},{"key":"rf49_633","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010019"},{"key":"rf50_634","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"rf51_635","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02631-0"},{"key":"rf52_636","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000171405.46113.bf"},{"key":"rf53_637","first-page":"174","volume":"39","author":"Mobius U","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf54_638","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000131343.53419.04"},{"key":"rf55_639","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200203080-00008"},{"key":"rf56_640","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000167156.44980.33"},{"key":"rf57_641","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.aids.0000174451.78497.8f","volume":"19","author":"Calza L","year":"2005","journal-title":"AIDS"},{"key":"rf58_642","doi-asserted-by":"publisher","DOI":"10.1086\/497273"},{"key":"rf59_643","unstructured":"De Truchis P, Kirstetter M, Perier A, etal Treatment of hypertriglyceridemia in HIV-infected patients under HAART, by (n-3) polyunsaturated fatty acids: a double-blind randomized prospective trial in 122 patients [abstract 39]. In: Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections (Boston). Available at: http:\/\/www.retroconference.org\/2005\/cd\/Abstracts\/24475.htm. Accessed 24 July 2006."},{"key":"rf60_644","unstructured":"Gerber J, Kitch D, Aberg J, etal The safety and efficacy of fish oil in combination with fenofibrate in subjects on ART with hypertriglyceridemia who had an incomplete response to either agent alone: results of ACTG A5186 [abstract 146]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). 2006."},{"key":"rf61_645","doi-asserted-by":"publisher","DOI":"10.1086\/422144"},{"key":"rf62_646","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/diacare.28.suppl_1.S4","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"key":"rf63_647","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000181011.62385.91"},{"key":"rf64_648","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200303010-00009"},{"key":"rf65_649","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000165910.89462.2f"},{"key":"rf66_650","doi-asserted-by":"publisher","DOI":"10.1086\/324353"},{"key":"rf67_651","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200403010-00008"},{"key":"rf68_652","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200207050-00005"},{"key":"rf69_653","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2005.162"},{"key":"rf70_654","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.4.340"},{"key":"rf71_655","unstructured":"AIDS Clinical Trials Group (ACTG) metabolic complications guides. Available at: http:\/\/aactg.s-3.com\/metabolic\/lactic.pdf. Accessed 24 July 2006."},{"key":"rf72_656","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/135965350400900210","volume":"9","author":"McComsey GA","year":"2004","journal-title":"Antivir Ther"},{"key":"rf73_657","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311210-00012"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/43\/5\/645\/1361720\/43-5-645.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T12:23:13Z","timestamp":1683548593000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/507333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1086\/507333"],"URL":"https:\/\/doi.org\/10.1086\/507333","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}